The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Key challenges for delivering clinical impact with artificial intelligence
Open accessAbstract
Background: Artificial intelligence (AI) research in healthcare is accelerating rapidly, with potential applications being demonstrated across various domains of medicine. However, there are currently limited examples of such techniques being successfully deployed into clinical practice. This article explores the main challenges and limitations of AI in healthcare, and considers the steps required to translate these potentially transformative technologies from research to clinical practice. Main body: Key challenges for the translation of AI systems in healthcare include those intrinsic to the science of machine learning, logistical difficulties in implementation, and consideration of the barriers to adoption as well as of the necessary sociocultural or pathway changes. Robust peer-reviewed clinical evaluation as part of randomised controlled trials should be viewed as the gold standard for evidence generation, but conducting these in practice may not always be appropriate or feasible. Performance metrics should aim to capture real clinical applicability and be understandable to intended users. Regulation that balances the pace of innovation with the potential for harm, alongside thoughtful post-market surveillance, is required to ensure that patients are not exposed to dangerous interventions nor deprived of access to beneficial innovations. Mechanisms to enable direct comparisons of AI systems must be developed, including the use of independent, local and representative test sets. Developers of AI algorithms must be vigilant to potential dangers, including dataset shift, accidental fitting of confounders, unintended discriminatory bias, the challenges of generalisation to new populations, and the unintended negative consequences of new algorithms on health outcomes. Conclusion: The safe and timely translation of AI research into clinically validated and appropriately regulated systems that can benefit everyone is challenging. Robust clinical evaluation, using metrics that are intuitive to clinicians and ideally go beyond measures of technical accuracy to include quality of care and patient outcomes, is essential. Further work is required (1) to identify themes of algorithmic bias and unfairness while developing mitigations to address these, (2) to reduce brittleness and improve generalisability, and (3) to develop methods for improved interpretability of machine learning predictions. If these goals can be achieved, the benefits for patients are likely to be transformational.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Overall, translating research techniques into clinical practice, establishing accountability for clinical decisions [129], and the extent of disclosure of ML integration are the major challenges associated with the use of ML models [135].”
From Machine learning-based clinical decision support using laboratory data (2024) · cites this paper as [135]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similar to internal validation of the AIPM, external AIPM model validation can be based on discrimination (area under the receiver operating characteristic curve, sensitivity, specificity, positive and negative predictive values), calibration (calibration plot)5,6,13,17,49,56,78, and Decision Curve Analysis5,6,17,49,68,72.”
From Guidelines and quality criteria for artificial intelligence-based prediction models in healthcare: a scoping review (2022) · cites this paper as [72]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Still, AIPM updating, site-specific training or recalibration might be needed to adapt an existing AIPM to a different healthcare setting3,5,9,60,68,72.”
From Guidelines and quality criteria for artificial intelligence-based prediction models in healthcare: a scoping review (2022) · cites this paper as [72]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“External validation is ideally performed by independent researchers from other institutions or settings3,8,10,16,27,68,72.”
From Guidelines and quality criteria for artificial intelligence-based prediction models in healthcare: a scoping review (2022) · cites this paper as [72]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A feasibility study or implementation pilot is recommended preceding an impact study to ensure correct and safe use in healthcare practice10,18,72.”
From Guidelines and quality criteria for artificial intelligence-based prediction models in healthcare: a scoping review (2022) · cites this paper as [72]
Experimental — accuracy not yet measured
58 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatologist-level classification of skin cancer with deep neural networks
Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017) · Nature · doi:10.1038/nature21056 · Cited by 14,362
High-performance medicine: the convergence of human and artificial intelligence
Topol, E. J. (2019) · Nature Medicine · doi:10.1038/s41591-018-0300-7 · Cited by 10,450
Gulshan, V., Peng, L., Coram, M., Stumpe, M. C., Wu, D., Narayanaswamy, A., Venugopalan, S., Widner, K., Madams, T., Cuadros, J., et al. (2016) · JAMA · doi:10.1001/jama.2016.17216 · Cited by 7,697
“Why Should I Trust You?”: Explaining the Predictions of Any Classifier
Ribeiro, M., Singh, S., & Guestrin, C. (2016) · Proceedings of the 2016 Conference of the North American Chapter of the Association for Computational Linguistics: Demonstrations · doi:10.18653/v1/n16-3020 · Cited by 6,682
A guide to deep learning in healthcare
Esteva, A., Robicquet, A., Ramsundar, B., Kuleshov, V., DePristo, M., Chou, K., Cui, C., Corrado, G., Thrun, S., & Dean, J. (2019) · Nature Medicine · doi:10.1038/s41591-018-0316-z · Cited by 5,312
Self-citationSaito, T., & Rehmsmeier, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118432 · Cited by 5,309
The Triple Aim: Care, Health, And Cost
Berwick, D. M., Nolan, T. W., & Whittington, J. (2008) · Health Affairs · doi:10.1377/hlthaff.27.3.759 · Cited by 5,136
Wang, X., Peng, Y., Lu, L., Lu, Z., Bagheri, M., & Summers, R. M. (2017) · 2017 IEEE Conference on Computer Vision and Pattern Recognition (CVPR) · doi:10.1109/cvpr.2017.369 · Cited by 4,616
From Triple to Quadruple Aim: Care of the Patient Requires Care of the Provider
Bodenheimer, T., & Sinsky, C. (2014) · The Annals of Family Medicine · doi:10.1370/afm.1713 · Cited by 3,462
Hannun, A. Y., Rajpurkar, P., Haghpanahi, M., Tison, G. H., Bourn, C., Turakhia, M. P., & Ng, A. Y. (2019) · Nature Medicine · doi:10.1038/s41591-018-0268-3 · Cited by 3,148
Cited by
Rajpurkar, P., Chen, E., Banerjee, O., & Topol, E. J. (2022) · Nature Medicine · doi:10.1038/s41591-021-01614-0 · Cited by 3,212
A Survey on Explainable Artificial Intelligence (XAI): Toward Medical XAI
Tjoa, E., & Guan, C. (2021) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2020.3027314 · Cited by 2,524
Artificial intelligence in healthcare: transforming the practice of medicine
Bajwa, J., Munir, U., Nori, A., & Williams, B. (2021) · Future Healthcare Journal · doi:10.7861/fhj.2021-0095 · Cited by 1,856
Liu, X., Cruz Rivera, S., Moher, D., Calvert, M. J., Denniston, A. K., The SPIRIT-AI and CONSORT-AI Working Group, SPIRIT-AI and CONSORT-AI Steering Group, Chan, A.-W., Darzi, A., Holmes, C., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1034-x · Cited by 1,421
Self-citationWamba-Taguimdje, S.-L., Fosso Wamba, S., Kala Kamdjoug, J. R., & Tchatchouang Wanko, C. E. (2020) · Business Process Management Journal · doi:10.1108/bpmj-10-2019-0411 · Cited by 1,280
Metadata
- Authors
- Kelly, C. J., Karthikesalingam, A., Suleyman, M., Corrado, G., & King, D.
- Affiliations
- Google (United Kingdom) (GB)
- Google DeepMind (United Kingdom) (GB)
- Corresponding author
- Kelly, Christopher J.
- Venue
- BMC Medicine
- Published
- 2019-10-29
- Volume
- 17
- Issue
- 1
- Pages
- 195-195
- ISSN
- 1741-7015 (ISSN-L)
- PMC
- PMC6821018
- OpenAlex
- W2982580298
- Cited by
- 3,136
- References
- 97
- Citations by year
- 2026: 1116 · 2025: 600 · 2024: 401 · 2023: 359 · 2022: 298 · 2021: 220 · 2020: 136 · 2019: 3
- FWCI
- 52.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- BMC Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (acceptedVersion)
- Funders
- Topics
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Physical Sciences › Computer Science › Artificial Intelligence › Ethics and Social Impacts of AI
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Keywords
- artificial intelligence in healthcare, clinical translation of AI, implementation barriers, randomized controlled trials, performance indicators, AI regulation, post-marketing surveillance, algorithmic bias, distribution shift, generalizability, interpretability, algorithmic fairness
- MeSH terms
- Algorithms, Artificial Intelligence, Delivery of Health Care, Humans, Peer Review
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Key challenges for delivering clinical impact with artificial intelligence. https://app.cochat.ai/papers/10.1186/s12916-019-1426-2
- The paper
- Kelly, C. J., Karthikesalingam, A., Suleyman, M., Corrado, G., & King, D. (2019). Key challenges for delivering clinical impact with artificial intelligence. BMC Medicine. https://doi.org/10.1186/s12916-019-1426-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.